SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending as the community speculates on upcoming ecosystem expansion and utility integrations, with many users actively accumulating positions in anticipation of a potential recovery. Sentiment remains a mix of cautious optimism and bullish conviction, driven by the project's high wallet holder count and ongoing discussions around its role on the Base chain.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing significant trading activity and community buzz driven by anticipation for upcoming clinical retina data, a new multi-pack product launch, and high expectations for their quarterly revenue update. The community remains hyper-focused on the company's long-term growth trajectory and the potential for a short squeeze as investors weigh aggressive sales expansion against the company's forward-looking guidance.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors react to a strategic pivot toward developing its own clinical-stage pipeline, bolstered by a significant T-cell engager collaboration with Jazz Pharmaceuticals. The community is actively discussing the potential for an upcoming Phase 2 clinical readout for the ABCL635 antibody to drive valuation, while technical traders note a surge in volume and sentiment shifting from discovery-focused models to long-term clinical execution.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to the company's recent regulatory milestone, where the European Medicines Agency approved the use of commercially manufactured GP2 peptide for the Phase III FLAMINGO-01 trial. Investors are actively discussing the expanded site network and improved enrollment efficiency, with many community members highlighting the stock's significant long-term potential and expressing optimism about upcoming data readouts and potential strategic partnerships.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is facing intense community scrutiny and downward pressure as investors express concerns over potential share dilution and an anticipated reverse stock split. The discourse is heavily fueled by skepticism regarding the company's long-term value, with many participants actively debating whether to short the stock or avoid it entirely due to its ties to the Trump family and weak operational performance.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee Inc. is currently a focal point for investors as the community debates the stock's long-term growth potential and store expansion in the U.S. against persistent price volatility and concerns over its OTC listing status. Sentiment remains sharply divided, with long-term shareholders highlighting the company's robust revenue growth and international footprint, while others voice frustration over stagnant price action and the lack of a formal relisting timeline.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing a surge in trading volume and investor attention, with the community actively speculating about potential merger activity and an upcoming regulatory filing catalyst. Retail discussions are dominated by debates over institutional manipulation, the stock's long-term valuation relative to peers, and frustration over persistent price volatility.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending as investors focus on the strong commercial momentum of Ibtrozi and its best-in-class performance in ROS1-positive NSCLC, particularly concerning CNS efficacy and frontline adoption. The community is actively discussing the company's robust balance sheet and potential for future M&A, viewing current price action as an accumulation opportunity ahead of upcoming pipeline updates for safusidenib and broader platform developments.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
